Product Information

DROXIDOPA 200 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.1149 per EA under NDC 70710139009. Its NADAC has been published 188 times since Feb 22, 2023.

FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DROXIDOPA 200 MG CAPSULE

Droxidopa
$1.1149per EA

Strength

200 mg/1

NDC

70710139009

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DROXIDOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA211818

FDA Approved

2/18/2021

TE Code

AB

On Market Since

2/19/2021

Pharmacological Classes

Catecholamines
Increased Blood Pressure

Price Statistics

The NADAC for DROXIDOPA 200 MG CAPSULE has been published 188 times since Feb 22, 2023, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1149 per EA
All-time high$2.3453 (Jul 10, 2024)
All-time low$0.8820 (Aug 19, 2026)
52-week high$1.7346
52-week low$0.8820
Median price$1.7315
Average price$1.7151
Largest weekly change-25.1% (Jul 17, 2024)
Weeks tracked188
Tracking sinceFeb 22, 2023

Price History

1W

+13.1%

1M

+23.8%

3M

+26.4%

6M

-17.8%

1Y

-32.5%

3Y

-47.6%

5Y

N/A

All

-47.6%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DROXIDOPA 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for DROXIDOPA 200 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.1149 per EA (NDC 70710139009), effective Nov 18, 2026.

How has the price of DROXIDOPA 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for DROXIDOPA 200 MG CAPSULE has declined 47.6%. It has been tracked across 188 weekly CMS publications since Feb 22, 2023.

What are the highest and lowest recorded NADAC prices for DROXIDOPA 200 MG CAPSULE?

Since Feb 22, 2023, the NADAC for DROXIDOPA 200 MG CAPSULE has ranged from a low of $0.8820 (Aug 19, 2026) to a high of $2.3453 (Jul 10, 2024), with a median of $1.7315 per EA.

Are there cheaper alternatives to DROXIDOPA 200 MG CAPSULE?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DROXIDOPA 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures DROXIDOPA 200 MG CAPSULE?

DROXIDOPA 200 MG CAPSULE (NDC 70710139009) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.